BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 37043115)

  • 1. Volume changes of hippocampal and amygdala subfields in patients with mild cognitive impairment and Alzheimer's disease.
    Qu H; Ge H; Wang L; Wang W; Hu C
    Acta Neurol Belg; 2023 Aug; 123(4):1381-1393. PubMed ID: 37043115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do multiple system atrophy and Parkinson's disease show distinct patterns of volumetric alterations across hippocampal subfields? An exploratory study.
    Wang N; Zhang L; Yang H; Luo X; Fan G
    Eur Radiol; 2019 Sep; 29(9):4948-4956. PubMed ID: 30796577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
    He P; Qu H; Cai M; Liu W; Gu X; Ma Q
    Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of hippocampal subfields in neurodegenerative disease progression analyzed with a multi-scale attention-based network.
    Xu H; Liu Y; Wang L; Zeng X; Xu Y; Wang Z
    Neuroimage Clin; 2023; 38():103370. PubMed ID: 36948139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated Hippocampal Subfield Volumetric Analyses in Atypical Alzheimer's Disease.
    Gabere M; Thu Pham NT; Graff-Radford J; Machulda MM; Duffy JR; Josephs KA; Whitwell JL;
    J Alzheimers Dis; 2020; 78(3):927-937. PubMed ID: 33074228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Atrophy Pattern of Hippocampal Subfields in Patients with Progressive and Stable Mild Cognitive Impairment: A Longitudinal MRI Study.
    Zeng Q; Li K; Luo X; Wang S; Xu X; Li Z; Zhang T; Liu X; Fu Y; Xu X; Wang C; Wang T; Zhou J; Liu Z; Chen Y; Huang P; Zhang M;
    J Alzheimers Dis; 2021; 79(1):237-247. PubMed ID: 33252076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo analysis of hippocampal subfield atrophy in mild cognitive impairment via semi-automatic segmentation of T2-weighted MRI.
    Pluta J; Yushkevich P; Das S; Wolk D
    J Alzheimers Dis; 2012; 31(1):85-99. PubMed ID: 22504319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal subfield CA2+3 exhibits accelerated aging in Alcohol Use Disorder: A preliminary study.
    Zahr NM; Pohl KM; Saranathan M; Sullivan EV; Pfefferbaum A
    Neuroimage Clin; 2019; 22():101764. PubMed ID: 30904825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volumetric changes within hippocampal subfields in Alzheimer's disease continuum.
    Hari E; Kurt E; Bayram A; Kizilates-Evin G; Acar B; Demiralp T; Gurvit H
    Neurol Sci; 2022 Jul; 43(7):4175-4183. PubMed ID: 35041116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal Stratum Radiatum, Lacunosum, and Moleculare Sparing in Mild Cognitive Impairment.
    Su L; Hayes L; Soteriades S; Williams G; Brain SAE; Firbank MJ; Longoni G; Arnold RJ; Rowe JB; O'Brien JT
    J Alzheimers Dis; 2018; 61(1):415-424. PubMed ID: 29171994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrophy of hippocampal subfields relates to memory decline during the pathological progression of Alzheimer's disease.
    Xiao Y; Hu Y; Huang K;
    Front Aging Neurosci; 2023; 15():1287122. PubMed ID: 38149170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrophy asymmetry in hippocampal subfields in patients with Alzheimer's disease and mild cognitive impairment.
    Jahanshahi AR; Naghdi Sadeh R; Khezerloo D
    Exp Brain Res; 2023 Feb; 241(2):495-504. PubMed ID: 36593344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study.
    Liu G; Liu C; Qiu A;
    Hum Brain Mapp; 2021 Jun; 42(9):2931-2940. PubMed ID: 33739550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in hippocampal subfield volume are seen in phenotypic variants of early onset Alzheimer's disease.
    Parker TD; Slattery CF; Yong KXX; Nicholas JM; Paterson RW; Foulkes AJM; Malone IB; Thomas DL; Cash DM; Crutch SJ; Fox NC; Schott JM
    Neuroimage Clin; 2019; 21():101632. PubMed ID: 30558867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal subfield volumes in mild cognitive impairment and alzheimer's disease: a systematic review and meta-analysis.
    Zhang J; Xie L; Cheng C; Liu Y; Zhang X; Wang H; Hu J; Yu H; Xu J
    Brain Imaging Behav; 2023 Dec; 17(6):778-793. PubMed ID: 37768441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygenic score for Alzheimer's disease identifies differential atrophy in hippocampal subfield volumes.
    Kannappan B; Gunasekaran TI; Te Nijenhuis J; Gopal M; Velusami D; Kothandan G; Lee KH;
    PLoS One; 2022; 17(7):e0270795. PubMed ID: 35830443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of hippocampal subfields in the progression of cognitive decline related to Parkinson's disease.
    Foo H; Mak E; Chander RJ; Ng A; Au WL; Sitoh YY; Tan LC; Kandiah N
    Neuroimage Clin; 2017; 14():37-42. PubMed ID: 28116240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its subfields in mild cognitive impairment, Alzheimer's disease, and dementia with Lewy bodies.
    Mak E; Gabel S; Su L; Williams GB; Arnold R; Passamonti L; Vazquez Rodríguez P; Surendranathan A; Bevan-Jones WR; Rowe JB; O'Brien JT
    Int Psychogeriatr; 2017 Apr; 29(4):545-555. PubMed ID: 28088928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can hippocampal subfield measures supply information that could be used to improve the diagnosis of Alzheimer's disease?
    Kannappan B; Te Nijenhuis J; Choi YY; Lee JJ; Choi KY; Balzekas I; Jung HY; Choe Y; Song MK; Chung JY; Ha JM; Choi SM; Kim H; Kim BC; Jo HJ; Lee KH
    PLoS One; 2022; 17(11):e0275233. PubMed ID: 36327265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.